Hitomi Sudo

1.0k citations

56 papers · 766 indexed · h-index 17

Impact in

Radiology, Nuclear Medicine and Imaging top 5%
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 25
- Radiopharmaceutical Chemistry and Applications 15
- Monoclonal and Polyclonal Antibodies Research 6
- Medical Imaging Techniques and Applications 6
Oncology 23

Co-authors: Atsushi B. Tsuji (49 shared papers)Aya Sugyo (47 shared papers)Tsuneo Saga (30 shared papers)Tatsuya Higashi (19 shared papers)Mitsuru Koizumi (13 shared papers)Kotaro Nagatsu (11 shared papers)Chisato Yoshida (6 shared papers)Okio Hino (4 shared papers)
Journals: Nuclear Medicine Communications (5 papers)Nuclear Medicine and Biology (4 papers)Cancer Science (4 papers)Oncology Reports (3 papers)International Journal of Molecular Sciences (3 papers)
Partner nations: Japan United States New Zealand

In The Last Decade

Hitomi Sudo

56 papers receiving 755 citations

Peers

Countries citing papers authored by Hitomi Sudo

Since Specialization

Citations

This map shows the geographic impact of Hitomi Sudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Sudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Sudo more than expected).

Fields of papers citing papers by Hitomi Sudo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitomi Sudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Sudo. The network helps show where Hitomi Sudo may publish in the future.

Co-authors

The 25 scholars most cited alongside Hitomi Sudo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hitomi Sudo Line = papers co-authored together Hitomi Sudo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model European Journal of Nuclear Medicine and Molecular Imaging ·Yasuhiro Ohshima, Hitomi Sudo, Shigeki Watanabe, Kotaro Nagatsu, Atsushi B. Tsuji, Tetsuya Sakashita, Yoichi M. Ito, Keiichiro Yoshinaga, Tatsuya Higashi, Noriko S. Ishioka	2018	69
2	Knockdown of COPA, Identified by Loss-of-Function Screen, Induces Apoptosis and Suppresses Tumor Growth in Mesothelioma Mouse Model Genomics ·Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Masakazu Kohda, Chizuru Sogawa, Chisato Yoshida, Yoshi-nobu Harada, Okio Hino, Tsuneo Saga	2010	59
3	AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma International Journal of Oncology ·Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Masaaki Abe, Okio Hino, Tsuneo Saga	2013	39
4	Evaluation of 89Zr-Labeled Human Anti-CD147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer PLoS ONE ·Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Kotaro Nagatsu, Mitsuru Koizumi, Yoshinori Ukai, Gene Kurosawa, Ming Rong Zhang, Yoshikazu Kurosawa, Tsuneo Saga	2013	34
5	Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells. PubMed ·Masahito Fushimi, Y. Tokura, Y. SACHI, Hideo Hashizume, Hitomi Sudo, Hisashi Wakita, Fukumi Furukawa, Masaharu Takigawa	1996	32
6	Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer PLoS ONE ·Chisato Yoshida, Atsushi B. Tsuji, Hitomi Sudo, Aya Sugyo, Tatsuya Kikuchi, Mitsuru Koizumi, Yasushi Arano, Tsuneo Saga	2013	28
7	Preclinical Evaluation of the Acute Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent 211At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice Translational Oncology ·Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Kotaro Nagatsu, Katsuyuki Minegishi, Noriko S. Ishioka, Hiroshi Ito, Keiichiro Yoshinaga, Tatsuya Higashi	2019	27
8	ZDHHC8 knockdown enhances radiosensitivity and suppresses tumor growth in a mesothelioma mouse model Cancer Science ·Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Yuriko Ogawa, Masashi Sagara, Tsuneo Saga	2011	26
9	Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models PLoS ONE ·Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Maki Okada, Mitsuru Koizumi, H. Satoh, Gene Kurosawa, Yoshikazu Kurosawa, Tsuneo Saga	2015	25
10	FZD10‐targeted α‐radioimmunotherapy with ²²⁵Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model Cancer Science ·Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Yosuke Harada, Satoshi Nagayama, Toyomasa Katagiri, Yusuke Nakamura, Tatsuya Higashi	2021	24
11	C-kit-targeted imaging of gastrointestinal stromal tumor using radiolabeled anti-c-kit monoclonal antibody in a mouse tumor model Nuclear Medicine and Biology ·Chizuru Sogawa, Atsushi B. Tsuji, Hitomi Sudo, Aya Sugyo, Chisato Yoshida, Kenichi Odaka, Tomoya Uehara, Yasushi Arano, Mitsuru Koizumi, Tsuneo Saga	2009	23
12	Preclinical evaluation of 89Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model Nuclear Medicine Communications ·Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Kotaro Nagatsu, Mitsuru Koizumi, Yoshinori Ukai, Gene Kurosawa, Ming-Rong Zhang, Yoshikazu Kurosawa, Tsuneo Saga	2014	20
13	Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts Nuclear Medicine and Biology ·Atsushi B. Tsuji, Chizuru Sogawa, Aya Sugyo, Hitomi Sudo, Jun Toyohara, Mitsuru Koizumi, Masaaki Abe, Okio Hino, Yoshi-nobu Harada, Takako Furukawa, Kazutoshi Suzuki, Tsuneo Saga	2009	19
14	Development of positron emission tomography probe of 64Cu-labeled anti-C-kit 12A8 Fab to measure protooncogene C-kit expression Nuclear Medicine and Biology ·Chisato Yoshida, Atsushi B. Tsuji, Hitomi Sudo, Aya Sugyo, Chizuru Sogawa, Masayuki Inubushi, Tomoya Uehara, Toshimitsu Fukumura, Mitsuru Koizumi, Yasushi Arano, Tsuneo Saga	2010	19
15	Development of Radiohalogenated Osimertinib Derivatives as Imaging Probes for Companion Diagnostics of Osimertinib Journal of Medicinal Chemistry ·Kenji Mishiro, Ryuichi Nishii, Izumi Sawazaki, Tomoki Sofuku, Takeshi Fuchigami, Hitomi Sudo, Nurmaya Effendi, A. Makino, Yasushi Kiyono, Kazuhiro Shiba, Junichi Taki, Seigo Kinuya, Kazuma Ogawa	2022	19
16	Development of positron emission tomography imaging by 64Cu-labeled Fab for detecting ERC/mesothelin in a mesothelioma mouse model Nuclear Medicine Communications ·Chisato Yoshida, Chizuru Sogawa, Atsushi B. Tsuji, Hitomi Sudo, Aya Sugyo, Tomoya Uehara, Okio Hino, Yukie Yoshii, Yasuhisa Fujibayashi, Toshimitsu Fukumura, Mitsuru Koizumi, Yasushi Arano, Tsuneo Saga	2010	17
17	A loss of function screen identifies nine new radiation susceptibility genes Biochemical and Biophysical Research Communications ·Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Takashi Imai, Tsuneo Saga, Yoshi-nobu Harada	2007	16
18	¹⁸F-FDG PET for Semiquantitative Evaluation of Acute Allograft Rejection and Immunosuppressive Therapy Efficacy in Rat Models of Liver Transplantation Journal of Nuclear Medicine ·Atsushi B. Tsuji, Miwa Morita, Xiao‐Kang Li, Chizuru Sogawa, Hitomi Sudo, Aya Sugyo, Masayuki Fujino, Atsushi Sugioka, Mitsuru Koizumi, Tsuneo Saga	2009	16
19	Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer International Journal of Molecular Sciences ·Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Mitsuru Koizumi, Yoshinori Ukai, Gene Kurosawa, Yoshikazu Kurosawa, Tsuneo Saga, Tatsuya Higashi	2018	15
20	Eosinophilic pustular folliculitis effectively treated with recombinant interferon-γ: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells British Journal of Dermatology ·Masahito Fushimi, Y. Tokura, Y. SACHI, Hideo Hashizume, Hitomi Sudo, Hisashi Wakita, Fukumi Furukawa, Masaharu Takigawa	1996	14

About Hitomi Sudo

Hitomi Sudo is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology, having authored 56 papers that have together received 766 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (15 papers), Occupational and environmental lung diseases (7 papers), Cell Adhesion Molecules Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Medical Imaging Techniques and Applications (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Medical Imaging and Pathology Studies (4 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (289 citations), Oncology (235 citations), Cancer Research (100 citations), Immunology and Allergy (40 citations) and Pulmonary and Respiratory Medicine (167 citations). Hitomi Sudo has collaborated with scholars based in Japan, United States and New Zealand. Frequent co-authors include Atsushi B. Tsuji, Aya Sugyo, Tsuneo Saga, Tatsuya Higashi, Mitsuru Koizumi, Kotaro Nagatsu, Chisato Yoshida, Okio Hino, Chizuru Sogawa and Yoshikazu Kurosawa. Their work appears in journals such as Nuclear Medicine Communications, Nuclear Medicine and Biology, Cancer Science, Oncology Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact